SYNODEX SENTINELX Trademark
Trademark Overview
On Monday, October 14, 2024, a trademark application was filed for SYNODEX SENTINELX with the United States Patent and Trademark Office. The USPTO has given the SYNODEX SENTINELX trademark a serial number of 98800679. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, August 7, 2025. This trademark is owned by Innodata Synodex, LLC. The SYNODEX SENTINELX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Platform as a service (PAAS) featuring computer software platforms for predictive artificial intelligence modeling to compile, process and analyze healthcare and medical records data; Platform as a service (PAAS) featuring computer software platforms for providing predictive artificial intelligence (AI) model output, AI model integration, and AI-powered data stories; Providing online non-downloadable computer software platforms for predictive artificial intelligence modeling; Providing temporary use of on-line non-downloadable software for providing predictive artificial intelligence (AI) model output, AI model integration, and AI-powered data stories; Software as a service (SAAS) services featuring software for providing predictive artificial intelligence (AI) model output, AI model integration, and AI-powered data stories
General Information
| Serial Number | 98800679 |
| Word Mark | SYNODEX SENTINELX |
| Filing Date | Monday, October 14, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Thursday, August 7, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | SYNODEX SENTINEL X |
| Goods and Services | Platform as a service (PAAS) featuring computer software platforms for predictive artificial intelligence modeling to compile, process and analyze healthcare and medical records data; Platform as a service (PAAS) featuring computer software platforms for providing predictive artificial intelligence (AI) model output, AI model integration, and AI-powered data stories; Providing online non-downloadable computer software platforms for predictive artificial intelligence modeling; Providing temporary use of on-line non-downloadable software for providing predictive artificial intelligence (AI) model output, AI model integration, and AI-powered data stories; Software as a service (SAAS) services featuring software for providing predictive artificial intelligence (AI) model output, AI model integration, and AI-powered data stories |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 14, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Innodata Synodex, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Ridgefield Park, NJ 07660 |
Trademark Events
| Event Date | Event Description |
| Monday, October 14, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 15, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 16, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, April 23, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 23, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 23, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, July 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 7, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, July 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
